Criterion validity of medicare chemotherapy claims in cancer and leukemia group B breast and lung cancer trial participants

Elizabeth B. Lamont, James E. Herndon, Jane C. Weeks, I. Craig Henderson, Rogerio Lilenbaum, Richard L. Schilsky, Nicholas A. Christakis, Lee S. Schwartzberg, Stephen George, Stephen Grubbs, Jeffrey Kirshner, George P. Cannelos, Marc S. Ernstoff, Jeffrey Crawford, Robert L. Comis, Edward Gelmann, H. Herbert Mauer, John W. Kugler, Placido P. Ferreira, Jonathan A. PolikoffMark Citron, Michael L. Grossbard, Mark Green, Alan P. Lyss, Rogerio Lilenbaum, Lewis Silverman, Michael J. O'Connell, Daniel R. Budman, William Sikov, Ellis Levine, Jack Goldberg, James N. Atkins, John Ellerton, Charles Coltman, Arnold D. Rubin, Stephen L. Graziano, Jeffrey Kirshner, Clara D. Bloomfield, Robert Diasio, Stephen L. Seagren, Alan P. Venook, Gini Fleming, Lawrence Feldman, Gerald H. Clamon, Martin Edelman, F. Mary Ellen Taplin, Bruce A. Peterson, Michael C. Perry, Anne Kessinger, Thomas C. Shea, Harvey B. Niell, Lynn M. Steinbrenner, Hyman B. Muss, John D. Roberts, David D. Hurd, Joseph J. Drabeek, Nancy Bartlett, Scott Wadler

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Criterion validity of medicare chemotherapy claims in cancer and leukemia group B breast and lung cancer trial participants'. Together they form a unique fingerprint.

Medicine & Life Sciences